BMS-345541 Is a Highly Selective Inhibitor of IκB Kinase That Binds at an Allosteric Site of the Enzyme and Blocks NF-κB-dependent Transcription in Mice (original) (raw)

Growth Inhibition of Multiple Myeloma Cells by a Novel I B Kinase Inhibitor

Takashi Okamoto

Clinical Cancer Research, 2005

View PDFchevron_right

Redesigning Kinase Inhibitors to Enhance Specificity

Ariel Fernandez

Journal of Medicinal Chemistry, 2008

View PDFchevron_right

BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice

Patrick Brassil

2003

View PDFchevron_right

Therapeutic effects of IkB kinase inhibitor during systemic inflammation

Vera Geraldes

International Immunopharmacology, 2020

View PDFchevron_right

Designing bisubstrate analog inhibitors for protein kinases

Keykavous Parang

Pharmacology & Therapeutics, 2002

View PDFchevron_right

Understanding how kinase-targeted therapies work

Sabrina Arena

Cell Cycle, 2008

View PDFchevron_right

Roles of ikB-alpha Protein Kinases in Activation of NF-kB in Breast Cancer

Gail Sonenshein

2005

View PDFchevron_right

Supplementary Materials, Tables 1-2, Figure Legends 1-8 from Identification and Characterization of NVP-BKM120, an Orally Available Pan-Class I PI3-Kinase Inhibitor

Tobi Nagel

2023

View PDFchevron_right

Running Title: MDM2 antagonists induce apoptosis in B-CLL

Esther Castaño

2006

View PDFchevron_right

Extended kinase profile and properties of the protein kinase inhibitor nilotinib

paul william manley

Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2010

View PDFchevron_right

Discovery of novel FMS kinase inhibitors as anti-inflammatory agents

Christopher Molloy

Bioorganic & Medicinal Chemistry Letters, 2008

View PDFchevron_right

ErbB receptor tyrosine kinase inhibitors as therapeutic agents

tawhid ahmad

Frontiers in Bioscience, 2002

View PDFchevron_right

Kinase Inhibition that Hinges on Halogen Bonds

Stephan Grant

Chemistry & Biology, 2011

View PDFchevron_right

Next‐generation Bruton's tyrosine kinase inhibitor BIIB091 selectively and potently inhibits B cell and Fc receptor signaling and downstream functions in B cells and myeloid cells

Douglas Donaldson

Clinical & Translational Immunology, 2021

View PDFchevron_right

A novel anti-melanoma SRC-family kinase inhibitor

Tarek Mansour

Oncotarget, 2019

View PDFchevron_right

Nuclear transcription factor-κB as a target for cancer drug development

Bharat Aggarwal

Leukemia, 2002

View PDFchevron_right

Identification of key cytosolic kinases containing evolutionarily conserved kinase tyrosine-based inhibitory motifs (KTIMs)

Martin Olivier

Developmental & Comparative Immunology, 2010

View PDFchevron_right

ABIN-1 Binds to NEMO/IKK and Co-operates with A20 in Inhibiting NF- B

Silvestro Formisano

Journal of Biological Chemistry, 2006

View PDFchevron_right

Comparison of the intrinsic kinase activity and substrate specificity of c-Abl and Bcr-Abl

Hoang Duc Phan

Bioorganic & Medicinal Chemistry Letters, 1998

View PDFchevron_right

Inhibition of the Canonical IKK/NFκB Pathway Sensitizes Human Cancer Cells to Doxorubicin

Federico Rojo

Cell Cycle, 2007

View PDFchevron_right

Structure of the Catalytic Domain of Human Protein Kinase C β II Complexed with a Bisindolylmaleimide Inhibitor

Stephan Grant

Biochemistry, 2006

View PDFchevron_right

BMC Biochemistry BioMed Central

Laura Tomassi

2009

View PDFchevron_right

Inhibitors that target protein kinases for the treatment of ovarian carcinoma

Benjamin Klein

American Journal of Obstetrics and Gynecology, 2003

View PDFchevron_right

Discovery of an Orally Efficacious Inhibitor of Anaplastic Lymphoma Kinase

Arup Ghose

Journal of Medicinal Chemistry, 2012

View PDFchevron_right

Discovery of BMS-641988, a Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer

Janet John

ACS Medicinal Chemistry Letters, 2015

View PDFchevron_right

156 A Novel Mutation in the Nfkb2 Gene Generates an NFκB2 ‘Super Repressor’

Natalie Sims

View PDFchevron_right

Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 2: Optimization of BX-517

Paul Hrvatin

Bioorganic & Medicinal Chemistry Letters, 2007

View PDFchevron_right

NF-κB regulator IκBNS in macrophages and diffuse large B cell lymphomas

Ronald Keller

2019

View PDFchevron_right

Computational Models of the NF-kB Signalling Pathway

Eva Qwarnstrom

Computation, 2014

View PDFchevron_right

Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition

Christopher Whitehead

Nature Structural & Molecular Biology, 2004

View PDFchevron_right

TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis

Paul Bourdon

Journal of Biological Chemistry, 1997

View PDFchevron_right

Rel/NF-κB and IκB factors in oncogenesis

Ignacio Luque

Seminars in Cancer Biology, 1997

View PDFchevron_right

Protein kinase CK2 – A key suppressor of apoptosis

Gretchen Unger

Advances in Enzyme Regulation, 2008

View PDFchevron_right

Kinase Inhibitors from Marine Sponges

Danielle Skropeta

Marine Drugs, 2011

View PDFchevron_right

The Stress-activated Protein Kinases

Joseph Avruch

Annals of the New York Academy of Sciences, 1995

View PDFchevron_right